Neeta Pandit-Taskar

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Neeta Pandit-Taskar

Sep 14, 2024, 11:12 | Insight

Piotr Wysocki: [89Zr]Zr-girentuximab is highly sensitive and specific for clear-cell RCC imaging

Piotr Wysocki recently shared a post on LinkedIn: “A phase 3 trial, ZIRCON, evaluated the use…

Sep 13, 2024, 07:51 | Blog

Neeraj Agarwal: Zr-girentuximab PET–CT for detecting ccRCC

Neeraj Agarwal shared a post on X, about recent paper published in The Lancet Oncology:…

Apr 21, 2024, 08:05 | Insight

New Paper Alert! Exploring the Potential of 18F-BMS-986229 PET for Noninvasive Assessment of PD-L1 Expression in Gastroesophageal Cancer

Exploring the Potential of 18F-BMS-986229 PET for Noninvasive Assessment of PD-L1 Expression in Gastroesophageal Cancer…

All: 3 Posts: 1 - 100

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023